Your browser doesn't support javascript.
loading
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.
Atanasoff, Kristina E; Brambilla, Luca; Adelsberg, Daniel C; Kowdle, Shreyas; Stevens, Christian S; Slamanig, Stefan; Hung, Chuan-Tien; Fu, Yanwen; Lim, Reyna; Tran, Linh; Allen, Robert; Sun, Weina; Duty, J Andrew; Bajic, Goran; Lee, Benhur; Tortorella, Domenico.
Afiliación
  • Atanasoff KE; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Brambilla L; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Adelsberg DC; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Kowdle S; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Stevens CS; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Slamanig S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Hung C-T; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Fu Y; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Lim R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Tran L; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
  • Allen R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Sun W; Sorrento Therapeutics, Inc., San Diego, California, USA.
  • Duty JA; Sorrento Therapeutics, Inc., San Diego, California, USA.
  • Bajic G; Sorrento Therapeutics, Inc., San Diego, California, USA.
  • Lee B; Sorrento Therapeutics, Inc., San Diego, California, USA.
  • Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
mBio ; 15(1): e0247723, 2024 Jan 16.
Article en En | MEDLINE | ID: mdl-38054729
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Pandemias / COVID-19 Límite: Humans Idioma: En Revista: MBio Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Pandemias / COVID-19 Límite: Humans Idioma: En Revista: MBio Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos